GYPA and Alzheimer disease: Conversely, percentages of Annexin V+ MVs derived from endothelium (CD31), erythrocytes (CD235a), and platelets (CD61) percentage (Figure 1E–G) of ALS patients were not different from those of healthy control subjects and AD patients.